Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H32ClN3O4 |
| Molecular Weight | 522.035 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@]1(O)CC(=O)OCC2=C1C=C3N(CC4=C3N=C5C=C(Cl)C(C)=CC5=C4CN6CCC(C)CC6)C2=O
InChI
InChIKey=KAQREZSTQZWNAG-GDLZYMKVSA-N
InChI=1S/C29H32ClN3O4/c1-4-29(36)12-26(34)37-15-21-22(29)10-25-27-20(14-33(25)28(21)35)19(13-32-7-5-16(2)6-8-32)18-9-17(3)23(30)11-24(18)31-27/h9-11,16,36H,4-8,12-15H2,1-3H3/t29-/m1/s1
Originator
Approval Year
Sample Use Guides
Phase I study. Elomotecan was administered as a 30-min intravenous infusion at doses ranging from 1.5 to 75 mg once every 3 weeks to 56 patients with advanced solid tumors. Plasma concentration data and adverse effects were modeled using the population approach.
Route of Administration:
Intravenous
The antiproliferative activity of elomotecan (BN 80927) was determined on various human tumor cell lines from a diverse set of target organs, including leukemia and solid tumors (colon, prostate, ovary, lung, bladder, and breast cell lines). BN80927 was an antiproliferative agent on all of the cell lines tested. On this set of cell lines, BN80927 has IC50 values 2–81 nM.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2843
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50176608
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY | |||
|
8589
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107746
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY | |||
|
C87275
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY | |||
|
100000174924
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY | |||
|
44KA9Q75GT
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY | |||
|
220998-10-7
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY | |||
|
216301
Created by
admin on Sat Dec 16 16:03:22 GMT 2023 , Edited by admin on Sat Dec 16 16:03:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
